Management & Regulatory

Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?
Management & Regulatory Is BioMarin's $60M Investment in Cork a Game-Changer for Biopharma?

BioMarin Pharmaceutical Inc. has made headlines with its announcement of a significant €60 million investment geared towards the expansion of its state-of-the-art facility located in Shanbally, Co. Cork. This ambitious expansion plan encompasses the construction of a new four-story laboratory b

How Did Maine Address Mental Health in Education During COVID-19?
Management & Regulatory How Did Maine Address Mental Health in Education During COVID-19?

The COVID-19 pandemic brought unprecedented challenges to educational systems worldwide, and Maine was no exception. When schools closed in March 2020, the Maine Department of Education (DOE) quickly recognized the need to address the mental health of both students and educators. This article

Freya Biosciences Secures $11.8M to Tackle Recurrent Bacterial Vaginosis
Management & Regulatory Freya Biosciences Secures $11.8M to Tackle Recurrent Bacterial Vaginosis

Freya Biosciences, a transatlantic biotech company specializing in women's health, has successfully secured a substantial $10.4 million investment from the Bill & Melinda Gates Foundation, along with an additional $1.4 million in financing from the Export and Investment Fund of Denmark.

How Will the Mesenchymal Stem Cells Market Expand by 2032?
Management & Regulatory How Will the Mesenchymal Stem Cells Market Expand by 2032?

The Mesenchymal Stem Cells (MSC) market is experiencing rapid growth, driven by an aging global population, advancements in regenerative medicine, and technological innovations in biotechnology. Valued at USD 3.2 billion in 2023, the market is anticipated to reach USD 9.72 billion by 2032, with a

Are Tissue Donation Regulations Failing To Ensure Quality And Safety?
Management & Regulatory Are Tissue Donation Regulations Failing To Ensure Quality And Safety?

The Rocky Mountain Lions Eye Bank (RMLEB) is a nonprofit organization responsible for procuring corneas in Wyoming and Colorado. Despite its noble mission, the organization faces significant operational challenges, regulatory issues, and a high-pressure work environment. These problems have led to

Immunomodulators Market to Reach $388.7 Billion by 2032
Management & Regulatory Immunomodulators Market to Reach $388.7 Billion by 2032

The Immunomodulators Market is on the cusp of exponential growth, with forecasts predicting an increase from roughly USD 217.7 billion in 2023 to an estimated USD 388.7 billion by 2032. This significant rise, characterized by an impressive compound annual growth rate (CAGR) of 6.7%, is largely

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later